This feature examines the impact of pharmacologic interventions on the treatment of the critically ill patient — an area of health care that has become increasingly complex. Recent advances in drug therapy (including evolving and controversial data) for adult intensive care unit patients will be reviewed and assessed in terms of clinical, humanistic, and economic outcomes. Direct questions or comments to Zachariah Thomas, PharmD at zachariah.thomas@gmail.com or Sandra Kane-Gill, PharmD, MSc, at kanesl@upmc.edu.
Get full access to this article
View all access options for this article.
References
1.
FoxworthJ.Stress ulcer prophylaxis in intensive care patients: an evidence-practice mismatch?Crit Care Nurs Q.2000; 22(4): 39–46.
2.
CookD.J., FullerH.D., GuyattG.H.Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med.1994; 330(6): 377–381.
3.
MauryE., TankovicJ., EbelA., OffenstadtG.Parisian Group of the Upper Gastrointestinal Bleeding Survey. An observational study of upper gastrointestinal bleeding in intensive care units: is Helicobacter pylori the culprit?Crit Care Med.2005; 33(7): 1513–1518.
DellingerR.P., CarletJ.M., MasurH.Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med.2004; 32(3): 858–873.
6.
Institute for Healthcare Improvement.http://www.ihi.org. Accessed September 9, 2007.
7.
StollmanN., MetzD.C.Pathophysiology and prophylaxis of stress ulcer in intensive care unit patients. J Crit Care.2005; 20(1): 35–45.
JungR., MacLarenR.Proton-pump inhibitors for stress ulcer prophylaxis in critically ill patients. Ann Pharmacother.2002; 36(12): 1929–1937.
10.
FennertyM.B.Pathophysiology of the upper gastrointestinal tract in the critically ill patient: rationale for the therapeutic benefits of acid suppression. Crit Care Med.2002; 30[suppl 6]: S351–S355.
11.
Ben-MenachemT., FogelR., PatelR.V.Prophylaxis for stress-related gastric hemorrhage in the medical intensive care unit. Ann Intern Med.1994; 121(8): 568–575.
12.
DevlinJ.W., Ben-MenachemT., UlepS.K., PetersM.J., FogelR.P., ZarowitzB.J.Stress ulcer prophylaxis in medical ICU patients: annual utilization in relation to the incidence of endoscopically proven stress ulceration. Ann Pharmacother.1998; 32(9): 869–874.
13.
ZandstraD.F., StoutenbeekC.P.The virtual absence of stress-ulceration related bleeding in ICU patients receiving prolonged mechanical ventilation without any prophylaxis. Intensive Care Med.1994; 20(5): 335–340.
14.
FaisyC., GuerotE., DiehlJ.L., IftimoviciE., FagonJ.Y.Clinically significant gastrointestinal bleeding in critically ill patients with and without stress-ulcer prophylaxis. Intensive Care Med.2003; 29(8): 1306–1313.
15.
KantorovaI., SvobodaP., ScheerP.Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial. Hepatogastroenterology.2004; 51(57): 757–761.
16.
DreyfussD.To consent or not to consent, that is (not) the (sole) question. “And there is nothing new under the sun.” Kohelet (also known as Ecclesiastes), 1: 9. Bible. Intensive Care Med.2004; 30(2): 180–182.
17.
TrybaM.Stress ulcer prophylaxis— quo vadis?Intensive Care Med.1994; 20: 311–313.
18.
RandolphA.G.Upper gastrointestinal bleeding in the pediatric intensive care unit: clinically important but questionably preventable. Pediatr Crit Care Med.2001; 2(4): 349–350.
19.
PetersonW.L.Prevention of upper gastrointestinal bleeding. N Engl J Med.1994; 330(6) 428–429.
20.
CookD.J., WittL.G., CookR.J., GuyattG.H.Stress ulcer prophylaxis in the critically ill: a meta-analysis. Am J Med.1991; 91(5): 519–527.
21.
CookD.J., GriffithL.E., WalterS.D.The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients. Crit Care.2001; 5(6): 368–375.
22.
CookD.J., LaineL.A., GuyattG.H., RaffinT.A.Nosocomial pneumonia and the role of gastric pH: a meta-analysis. Chest.1991; 100(1): 7–13.
23.
MessoriA., TrippoliS., VaianiM., GoriniM., CorradoA.Bleeding and pneumonia in intensive care patients given ranitidine and sucralfate for prevention of stress ulcer: meta-analysis of randomized controlled trials. BMJ.2000; 321(7269): 1103–1106.
24.
CookD.J., GuyattG., MarshallJ.A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. N Engl J Med.1998; 338(12): 791–797.
25.
LaheijR.J., SturkenboomM.C., HassingR.J., DielemanJ., StrickerB.H., JansenJ.B.Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA.2004; 292(16): 1955–1960.
26.
DialS., AlrasadiK., ManoukianC., HuangA., MenziesD.Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies. CMAJ.2004; 171(1): 33–38.
27.
DialS., DelaneyJ.A.C., BarkunA.N., SuissaS.Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA.2005; 294(23): 2989–2995.
28.
KahnJ.M., DoctorJ.N., RubenfeldG.D.Stress ulcer prophylaxis in mechanically ventilated patients: integrating evidence and judgment using a decision analysis. Intensive Care Med.2006; 32: 1151–1158.
29.
PennerR.M., BrindleyP.G., JackaM.J.Best evidence in critical care medicine: stress ulcer prophylaxis in the intensive care unit: damned if you do, damned if you don't. Can J Anaesth.2005; 52(6): 650–651.
